A Disproportionality Analysis of the Adverse Drug Events Associated with Lurasidone in Paediatric Patients Using the US FDA Adverse Event Reporting System (FAERS).

TY - JOUR

T1 - A Disproportionality Analysis of the Adverse Drug Events Associated with Lurasidone in Paediatric Patients Using the US FDA Adverse Event Reporting System (FAERS).

AU - Nishtala, Prasad

AU - Chyou, Teyuan

N1 - Rees, K.E., Chyou, T. & Nishtala, P.S. A Disproportionality Analysis of the Adverse Drug Events Associated with Lurasidone in Paediatric Patients Using the US FDA Adverse Event Reporting System (FAERS). Drug Saf (2020). https://doi.org/10.1007/s40264-020-00928-1

PY - 2020/4/4

Y1 - 2020/4/4

UR - http://www.scopus.com/inward/record.url?scp=85084635687&partnerID=8YFLogxK

U2 - 10.1007/s40264-020-00928-1

DO - 10.1007/s40264-020-00928-1

M3 - Letter

SN - 0114-5916

VL - 43

SP - 607

EP - 609

JO - Drug Safety

JF - Drug Safety

IS - 6

ER -